The United Laboratories International Holdings Limited

HKSE 3933.HK

The United Laboratories International Holdings Limited Free Cash Flow Yield on January 28, 2025: 5.12%

The United Laboratories International Holdings Limited Free Cash Flow Yield is 5.12% on January 28, 2025, a -38.92% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

The United Laboratories International Holdings Limited 52-week high Free Cash Flow Yield is 8.80% on January 30, 2024, which is 72.05% above the current Free Cash Flow Yield.
The United Laboratories International Holdings Limited 52-week low Free Cash Flow Yield is 4.73% on January 02, 2025, which is -7.64% below the current Free Cash Flow Yield.
The United Laboratories International Holdings Limited average Free Cash Flow Yield for the last 52 weeks is 6.31%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

HKSE: 3933.HK

The United Laboratories International Holdings Limited

CEO	Mr. Hoi Shan Tsoi
IPO Date	June 15, 2007
Location	Hong Kong
Headquarters	6 Fuk Wang Street
Employees	15,000
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Personal Care Plastics

Description

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.

Key trends

Past 5 years